Scheduled for Feb 11-12, 2013, 15th annual BIO CEO & Investor Conference will include more than 600 investors and 150 presenting companies. Plenary sessions will forecast year ahead in biotech and political outlook for next 4 years, while Business Roundtables will focus on reimbursement, navigating Chinese market, biopharma collaborations, and alternative venues to public markets. Therapeutic Workshops will address treatment for pancreatic cancer, chronic lymphocytic leukemia, and rare ...This story is related to the following:Trade Associations